PMID: 6109940Feb 7, 1981Paper

Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia

Lancet
D R IllingworthW E Connor

Abstract

Thriteen patients with heterozygous familial hypercholesterolaemia (FH) were sequentially treated with: a low-cholesterol, fat-restricted diet; diet and colestipol; and diet and colestipol and nicotinic acid. Concentrations of plasma cholesterol decreased from 415 +/- 69 mg/dl on diet alone to 327 +/- 54 mg/dl on colestipol and fell to 246 +/- 49 mg/dl on the combined drug regimen. Plasma concentrations of LDL cholesterol declined 24% on colestipol; the subsequent addition of nicotinic acid resulted in a further 31% fall so that values on the combined drug regimen were 47% below those seen on diet alone. HDL cholesterol levels were similar on both the diet (40 mg/dl) and colestipol (43 mg/dl) treatment periods but increased to 53 mg/dl on the combined drug regimen. Treatment resulted in significant decreases in the LDL:HDL ratio which fell from 8.4 on diet to 3.3 on the colestipol plus nicotinic acid regimen. In most patients with heterozygous FH, combined use of a bile acid sequestrant and nicotinic acid affords the opportunity to maintain a normal lipid profile. Prolonged use of this regimen may reduce the incidence of premature coronary atherosclerosis which naturally occurs in these patients.

Citations

Jul 1, 1991·Journal of Clinical Pharmacology·J M DroodW H Frishman
Jan 1, 1989·Pharmacology & Therapeutics·R A DavisL H Junker
Jul 23, 1983·Lancet·K F Michaelsen, K Taudorf
Dec 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·E E Sundberg, D R Illingworth
Sep 1, 1988·Postgraduate Medical Journal·L D CurtisD J Betteridge
Dec 1, 1984·The Journal of Clinical Investigation·D R Illingworth, G J Sexton
Aug 1, 1992·The American Journal of Medicine·P H Jones
Feb 1, 1987·American Heart Journal·J L Witztum
Jan 1, 1982·Critical Reviews in Clinical Laboratory Sciences·P N Durrington
Apr 1, 1987·The American Journal of Cardiology·J M HoegH B Brewer
Oct 30, 1987·The American Journal of Cardiology·D R Illingworth, S Bacon
Sep 1, 1982·Angiology·J C LaRosa
Nov 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S A NessimD H Blankenhorn
Jan 1, 1985·Acta Medica Scandinavica. Supplementum·J Stamler
Oct 1, 1986·British Journal of Clinical Pharmacology·C de PaolisA E Pontiroli
Jan 1, 1985·Acta Medica Scandinavica·A van de WielJ W Imhof
Jul 1, 1984·Progress in Cardiovascular Diseases·W V BrownH N Ginsberg
Sep 1, 1992·Current Problems in Cardiology·J S Prihoda, D R Illingworth

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.